Regulatory

Regulatory

Navamedic ASA – Mandatory notification of trade by primary insider

NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS

Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement

Navamedic ASA: Invitation to 2024 2nd quarter presentation

Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe

Navamedic ASA: Minutes of Annual General Meeting